This review looked at how the endothelin-1 (ET-1) system affects people with type 2 diabetes and diabetic kidney disease. The research found that a specific pathway in this system can cause damage to the kidneys over time. Because of this, certain medications called endothelin receptor antagonists are being studied to see if they can block this damage and reduce protein in the urine.
Clinical trials showed that these medications could help reduce albuminuria and certain kidney events. However, the review also noted that these drugs can sometimes cause side effects like fluid retention or heart failure. Because of these safety concerns, doctors are currently looking at different ways to use these treatments more safely.
While the findings are promising, the evidence is still being evaluated. ET-1 is also being studied as a way to find kidney disease earlier. Patients should talk to their doctors to understand how these findings might relate to their specific treatment plan.
Common questions
What is the role of endothelin-1 in kidney disease?
Endothelin-1 (ET-1) is a substance that can drive the progression of diabetic kidney disease. It causes damage to different parts of the kidney through specific pathways. Because of this, researchers are looking at ET-1 as a way to detect kidney disease earlier and as a way to understand how the disease progresses.
How do endothelin receptor antagonists work for patients?
These medications are designed to block the harmful effects of the ET-1 pathway. Clinical trials have shown that selective endothelin receptor antagonists can reduce albuminuria and certain kidney events. However, these drugs can also lead to side effects like fluid retention or heart failure, so their use requires careful consideration.
Are these treatments safe for people with diabetes?
While some trials show these medications can reduce kidney issues, they are associated with safety signals such as fluid retention and heart failure. Because of these risks, researchers are currently evaluating different combination strategies to make the treatment safer and more effective for patients.
